Le Lézard
Classified in: Health, Science and technology
Subjects: NEW PRODUCTS/SERVICES, HEALTH, Contests/Awards

Northeast Scientific Inc. wins 510(k) for Turbo-Elite Laser Atherectomy Catheter reprocessing


WATERBURY, Conn., July 26, 2022 (GLOBE NEWSWIRE) -- Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA clearance for reprocessing the Philips Spectranetics 0.9mm OTW Turbo-Elite laser atherectomy catheter. This is yet another first of its kind accomplishment for the Connecticut based company, as this is the first time the FDA has awarded a 510(k) clearance for reprocessing this type of atherectomy catheter.

The device is used to treat peripheral arterial disease (PAD) and emits high energy ultraviolet light to vaporize blockages inside the vessels. This laser catheter is one of the most used modalities for this common procedure with treatments done in acute care settings, surgical centers as well as in the Office Based Lab (OBL).

CEO and Founder, Craig Allmendinger discussed what this means to the company by saying, "It's validating to receive this clearance from the FDA after all the work our team undertook to meet the standards of earning a 510(k). The team at the FDA pushed us hard, and rightfully so, to prove that our methods and processes created an equivalent device to the original after reprocessing."

He went on to say, "There is no doubt now that what we are doing is helping redefine the medical device landscape as we add another device type to our reprocessing portfolio. As we continue to expand our device types and reach, we look to further help the OBL Physician and never compromise on patient safety."

Director of Product Development, Matt Farley had this to say; "We knew undertaking the Turbo-Elite device would be a difficult task as no-one had ever reprocessed a laser-based atherectomy device to date. Our team at all levels, from R&D to the product development team to the technicians helping do the work on the validations all have credit in making this product be cleared for reprocessing."

The company has said that it will have an additional announcement soon regarding when the 0.9mm OTW Turbo-Elite laser atherectomy catheter device will be available for sale.

With an unparalleled record for quality and safety across their 15 years of business, Northeast Scientific has reprocessed over 650,000 devices. Visit Smarthealth-care.com for more information.

Northeast Scientific, Inc.
2142 Thomaston Avenue Waterbury, CT 06704
Phone: 203-756-2111 Email: [email protected] 

 



These press releases may also interest you

at 20:50
Overture.law, the nation's leading attorney-to-attorney referral platform, launches their transformative new product, Inner Circles. This groundbreaking product empowers attorneys, law schools, bar associations, and affinity groups to build private...

at 20:09
BASIS Charter Schools proudly announce that two of its exceptional students have been named 2024 U.S. Presidential Scholars by the U.S. Department of Education. Matteo N. Huish from BASIS Mesa and Sruti Peddi from BASIS Scottsdale have been...

at 20:00
Kemal Hawa, co-chair of the Digital Infrastructure, Data Center and Cloud Computing Practice of global law firm Greenberg Traurig, LLP, will moderate a panel at DICE East 2024 May 22 in Reston, Virginia. Hawa, a member of the firm's Washington,...

at 19:45
WIO LLC, parent company of the global TV broadcast airings platform, WIOprotm, has announced a new strategic agreement with Gracenote, the global content data business unit of Nielsen, to address the longstanding challenge of accurately tracking and...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...



News published on and distributed by: